Cokol, Murat <br/><br/>
Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment.  [electronic resource] 

 -  PLoS computational biology  12 2018 
 - e1006677 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1553-7358 
<br/><br/><label>Standard No.: </label>10.1371/journal.pcbi.1006677  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acinetobacter baumannii--drug effects<br/>Anti-Bacterial Agents--administration & dosage<br/>Computational Biology<br/>Drug Interactions<br/>Drug Resistance, Multiple, Bacterial<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Escherichia coli--drug effects<br/>Genes, Bacterial--genetics<br/>Glycolysis--drug effects<br/>Glyoxylates--metabolism<br/>Host Microbial Interactions--drug effects<br/>Humans<br/>Metabolic Networks and Pathways--drug effects<br/>Microbial Sensitivity Tests<br/>Models, Biological<br/>Pharmacogenomic Testing--methods<br/>Software<br/>Systems Biology